JAK-IN-25 (compound 19) is a potent JAK inhibitor with IC50s of 6 nM, 21 nM, 8 nM, 1051 nM for TYK2, JAK1, JAK2, JAK3, respectively. JAK-IN-25 inhibits human whole blood IL-12 (HEB IL-12) with an IC50 of 28 nM. JAK-IN-25 has the potential for cancer research[1].
Molecular Weight:
379.37
Purity:
98.44
CAS Number:
[2127110-22-7]
Formula:
C19H17N5O4
Target:
JAK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted